2Lioyd RV, Jin L, Qian X, et al. Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol, 1997, 150:401-402.
3Erlanson M, Portin C, Linderholm B, et al. Expression of cyclin E and the cyclin-dependent kinese inhibitor p27 in malignant lymphoma-prognostic implications. Blood, 1998, 92:770-777.
4Lioyd RV, Erickson LA, Jin L, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol, 1999, 154:313-325.
3Martinez A,Bellosillo B,Bosch F,et al.Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival.Am Pathol,2004,164:501-510.
5AYRAULT O, ZINDY F, REHG J, et. al. Two tumor suppressors, p27Kipl and patched-1, collaborate to prevent medulloblastoma [ J ]. Mol Cancer Res, 2009, 7 (1) :33 -40.
6HAYETTE S, THOMAS X, BERTRAND Y, et al. Molaular analysis of cyclin-dependent kinase inhibitors in human leukemia [ J ]. Leukemia, 1997, 11 (10) : 1969 - 1999.
7WEGIEL B, EKBERG J, TALASILA K M, et. al. The role of VEGF and a functional link between VEGF and p27Kipl in acute myeloid leukemia[J]. Leukemia, 2009, 23 (2): 251 -261.
8YOKOZAWA T, YOWATARI M, LIDA H, et. al. Prognostic significance of the cell cycle inhibitor p27kipl in acute myeloid leukemia[ J]. Leukemia,2000,14( 1 ) : 18 -33.
9Larrea MD, Wander SA, Slingerland JM. p27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle, 2009, 21: 3455- 3461.
10Lee J, Kim SS, The function of p27 KIP1 during tumor development. Exp Mol Med, 2009, 41: 765-771.
